The FDA expects that randomized, controlled trial data on clinical outcomes will be needed before COVID-19 vaccines can be approved for patients who are 6 months to 64 years of age and do not have ...

The FDA will encourage new clinical trials on the widely used vaccines before approving them for children and healthy adults.

Previously, the FDA recommended COVID-19 vaccines for everyone aged 6 months and older. Under the new plan, shots for healthy ...

U.S. health officials, following recommendations by infectious disease experts, have been urging annual COVID-19 boosters for all Americans ages 6 months and older.

Aphios Corporation is pleased to announce that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for its patent application (Application No. 17/699,359), titled ...

Kennedy's move appears to shortcut the CDC's outside vaccine advisers, dropping COVID vaccines from the list recommended for ...

Donald Trump has a five-step plan to keep Republican control of the House of Representatives in 2026, as part of a desperate ...

The opioid epidemic, obesity, federal employee suicide and depression rates, and drug prices are on our readers’ minds.

Kennedy Jr. -- are restricting access to COVID shots that were a signature accomplishment of President Trump's first term and ...

The agency recommends manufacturers update their vaccines to target the JN.1 strain. At the same time, HHS head Robert F.

U.S. health officials will no longer recommend the COVID-19 vaccine for healthy children or healthy pregnant women, saying ...